GASTRIC PROTEASE INHIBITOR-CONTAINING DRUG FOR COMBINATION USE WITH INCRETIN MIMETIC

Title:

GASTRIC PROTEASE INHIBITOR-CONTAINING DRUG FOR COMBINATION USE WITH INCRETIN MIMETIC

Document Type and Number:

WIPO Patent Application WO/2021/166899

Kind Code:

A1

Abstract:

The present invention provides a drug having excellent preventive, alleviating, and/or therapeutic effects against disease such as obesity and diabetes. Specifically, the present invention provides a gastric protease inhibitor-containing drug for combination use with an incretin mimetic.

More Like This:

WO/2005/079850	NEW COMBINATIONS OF AN ANTI EMETIC AGENT AND AN ENKEPHALINASE INHIBITOR
WO/2021/203055	VIRAL ENTRY INHIBITORS AND RNA POLYMERASE INHIBITORS
WO/2023/034377	LYMPHOCYTE POPULATION AND METHODS FOR PRODUCING SAME

Inventors:

ITO KOJI (JP)
KANDA TOMOKO (JP)
KAWAGUCHI TETSUO (JP)
NARA FUTOSHI (JP)

Application Number:

PCT/JP2021/005680

Publication Date:

August 26, 2021

Filing Date:

February 16, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

UBE INDUSTRIES (JP)

International Classes:

A61K45/06; A61K31/198; A61K31/343; A61K31/365; A61K31/381; A61K31/41; A61K31/42; A61K45/00; A61P1/12; A61P1/16; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P5/50; A61P9/10; A61P9/12; A61P11/08; A61P13/12; A61P19/02; A61P19/06; A61P19/08; A61P19/10; A61P21/00; A61P25/16; A61P25/20; A61P25/28; A61P27/02; A61P29/00; A61P35/00; A61P43/00

Domestic Patent References:

WO2013187533A1	2013-12-19
WO2019088270A1	2019-05-09

Foreign References:

JP2009530395A	2009-08-27
JP2011519915A	2011-07-14
JP2017506627A	2017-03-09
JP2017505823A	2017-02-23

Attorney, Agent or Firm:

YAMAO, Norihito et al. (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: PAPER STRENGTHENING AGENT

Next Patent: ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING